Your browser doesn't support javascript.
loading
Epstein‒Barr virus-associated cellular immunotherapy.
Zhang, Yi; Lyu, Hairong; Guo, Ruiting; Cao, Xinping; Feng, Juan; Jin, Xin; Lu, Wenyi; Zhao, Mingfeng.
Afiliação
  • Zhang Y; First Center Clinic College of Tianjin Medical University, Tianjin, China. Electronic address: Zyi98722016@163.com.
  • Lyu H; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.
  • Guo R; First Center Clinic College of Tianjin Medical University, Tianjin, China.
  • Cao X; First Center Clinic College of Tianjin Medical University, Tianjin, China.
  • Feng J; Tianjin Jizhou District People's Hospital, Tianjin, China.
  • Jin X; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.
  • Lu W; Department of Hematology, Tianjin First Central Hospital, Tianjin, China. Electronic address: luwenyi0323@163.com.
  • Zhao M; Department of Hematology, Tianjin First Central Hospital, Tianjin, China. Electronic address: mingfengzhao@sina.com.
Cytotherapy ; 25(9): 903-912, 2023 09.
Article em En | MEDLINE | ID: mdl-37149797
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Burkitt / Infecções por Vírus Epstein-Barr Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Burkitt / Infecções por Vírus Epstein-Barr Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article